Scientific Reports, 2023 · DOI: 10.1038/s41598-023-32906-9 · Published: April 4, 2023
Adipose-derived stem cells (ADSCs) are popular in regenerative medicine because they are easily accessible and have low immunogenicity. However, their therapeutic efficacy can be weakened by the oxidative microenvironment of damaged tissue, which induces apoptosis of transplanted stem cells. Resveratrol (Res) is a natural compound that can regulate stem cell function. This study investigated whether incubating ADSCs with Res could improve their ability to promote peripheral nerve regeneration. The researchers cultured ADSCs in vitro and treated them with H2O2 to create an apoptosis model, then tested the effect of Res on ADSC proliferation and survival. In vivo, rats with sciatic nerve injuries were treated with ADSCs pretreated with Res, and their gait and nerve regeneration were observed. The results indicated that Res pretreatment significantly improved H2O2-induced apoptosis in ADSCs and enhanced their ability to promote sciatic nerve regeneration in rats.
Pretreating ADSCs with resveratrol could improve their survival and efficacy in nerve regeneration therapies.
The findings support further investigation into using resveratrol as an adjunct to stem cell therapies for peripheral nerve injuries in clinical settings.
Resveratrol or similar compounds could be developed as preconditioning agents to enhance the therapeutic potential of stem cells.